Planning initiation of SERENITY At-Home pivotal Phase 3 trial of BXCL501 for acute treatment of agitation associated with ...

Moreover, patents provide much-needed incentives for clinical research, including on new uses of approved products, which has ...

reports treatment of the first patient in a commercial setting with QUELIMMUNE™, its U.S. Food and Drug Administration (FDA)-approved, patented cell-directed extracorporeal therapy to treat ...

DENVER, July 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports treatment of the first patient in a commercial setting with QUELIMMUNE™, its U.S.

The Expert Edit features interviews with specialists about the products they swear by in their chosen field. For the latest installment, we spoke to Tandy Avery, VP of Product Development at ...

ZILBRYSQ is a C5 inhibitor and inhibits complement-mediated damage to the neuromuscular junction through its targeted dual mechanism of action. 2 Patients will be able to administer the ZILBRYSQ ...

THROGGS NECK, The Bronx (PIX11) – The takedown of an illegal vape shop in the Bronx turned up drug products marketed toward children, according to officials. The New York City Sheriff’s Office ...

Shoppers Drug Mart has struck a commercial partnership with Truvian Health, a San Diego-based startup that is seeking regulatory approval for its printer-sized devices to conduct on-the-spot blood ...